Health care stocks were flat to lower premarket Thursday with the iShares Biotechnology ETF (IBB) recently inactive and the Health Care Select Sector SPDR Fund (XLV) down 0.5% recently.
UnitedHealth Group (UNH) shares were down nearly 4% after the company reported a lower-than-expected Q4 revenue.
Incyte (INCY) and Syndax Pharmaceuticals (SNDX) said the US Food and Drug Administration has approved Niktimvo as a treatment for certain patients with chronic graft-versus-host disease who weigh at least 40 kg. Syndax Pharmaceuticals shares were 2% higher premarket.
Seres Therapeutics (MCRB) said it received a $50 million installment related to the sale of its VOWST business to Societe des Produits Nestle. Seres Therapeutics shares were down nearly 4% pre-bell.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。